International Markets Show Immediate and Increasing Demand for FDA-Cleared, CE Mark-Approved NeuroCap Device
The NeuroCap is a smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. (Credit: Natasha Connell on Unsplash)
Brain Scientific, a Florida-based applied science technology company, today announces a new distribution agreement with SysteMedic to meet market demand. Brain Scientific is targeting the pediatric and ICU markets for the NeuroCap in hospitals. SysteMedic plans to use the NeuroCap not only for pediatric and hospital ICUs but will also immediately leverage NeuroCaps in two new studies: one focusing on pediatric usage and the other focusing on ICU applications.
“We are very excited to bring Brain Scientific’s NeuroCap to our hospitals,” said Arik Yanco, CEO of SysteMedic. “Israel and SysteMedic are known for adopting cutting-edge technologies, and the NeuroCap will help us live up to that reputation in the field of EEG testing.”
SysteMedic, an industry leader for medical and lab supplies in Israel, will help Brain Scientific further expand its sales and distribution network to Brain Scientific’s key growth markets as Brain Scientific continues to position itself as the leader in the quickly emerging medical wearables space.
“The NeuroCap is game-changing in the neurodiagnostic wearable space,” said Hassan Kotob, CEO of Brain Scientific. “It has critical applications in pediatrics, emergency departments and ICUs, at-home care, and research. We have seen strong international demand following the CE certification of the NeuroCap, and we are happy to add SysteMedic to our team.”
The signing of SysteMedic comes on the heels of the addition of MVAP Medical Supplies, with both partnerships aimed at expanding the reach of Brain Scientific’s wearable products into key strategic markets worldwide.
Source: Company Press Release